Cingulate Raises $12 Million in Private Placement

Reuters02-17
Cingulate Raises $12 Million in Private Placement

Cingulate Inc. has announced the closing of a $12 million private placement, with shares priced at $5.04 each and 80% warrant coverage. The financing, which included participation from Falcon Creek Capital and insiders, is subject to a 180-day investor lock-up and will support operations and the potential commercial launch of CTx-1301, pending FDA approval. The securities were issued in an unregistered sale and are subject to a future resale registration statement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cingulate Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9655578-en) on February 17, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment